干细胞製造市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

到 2022 年，全球干细胞製造市场将达到 123 亿美元。 展望未来，IMARC Group 预测到 2028 年将达到 199 亿美元，显示 2023 年至 2028 年之间的增长率 (CAGR) 为 8.1%。

干细胞是构成动植物组织器官的未分化或部分分化的细胞。 干细胞通常来源于血液、骨髓、脐带、胚胎和胎盘。 在体内和实验室的适当条件下，干细胞可以分裂形成红细胞、血小板和白细胞等细胞，并发挥特殊功能。 干细胞广泛用于人类疾病模型、药物发现、无法治癒疾病的细胞疗法开发、基因疗法和组织工程。 干细胞被冷冻保存以维持活力并最大限度地减少遗传改变，因此用于替换受损的器官和组织并治疗各种疾病。

干细胞製造市场趋势

• 随着人们对干细胞治疗潜力的认识不断提高，风险投资 (VC) 对干细胞研究的投资不断增加，这主要推动了全球市场的发展。 除此之外，该产品在有效疾病管理、个性化医疗和基因组检测等应用中的广泛使用也对市场增长产生了积极影响。 此外，采用三维 (3D) 打印和微流体技术将多个生产过程集成到一个设备中以缩短生产时间和降低成本也在推动市场增长。 此外，製药行业越来越多地使用产品来製造用于治疗肿瘤、白血病和淋巴瘤的造血干细胞 (HSC) 和间充质干细胞 (MSC) 药物，这将成为另一个增长动力。 此外，该产品在研究应用中越来越多地用于创造新药以改善功能或帮助疾病进展，也显着推动了市场。 预计将推动市场的其他因素包括技术在组织和器官替代疗法中的应用越来越多、医疗基础设施的显着改善以及政府为促进公众健康而采取的各种措施的实施。

主要市场细分

• IMARC Group 分析了全球干细胞製造市场报告每个子部分的主要趋势，以及 2023 年至 2028 年全球、区域和国家层面的预测。 该报告根据产品、应用和最终用户对市场进行分类。

按产品细分

• 消耗品
• 培养基
• 其他
• 乐器
• 生物反应器、培养箱
• 细胞分选员
• 其他
• 干细胞系
• 造血干细胞 (HSC)
• 间充质干细胞 (MSC)
• 诱导多能干细胞 (iPSC)
• 胚胎干细胞 (ESC)
• 神经干细胞 (NSC)
• 多能成体祖细胞

按应用细分

• 研究用途
• 生命科学研究
• 药物发现和药物开发
• 临床应用
• 同种异体干细胞疗法
• 自体干细胞疗法
• 细胞/组织库申请

最终用户细分

• 製药和生物技术公司
• 学术机构、研究机构、合同研究机构
• 医院和手术中心
• 细胞/组织库
• 其他

按地区划分

• 北美
• 美国
• 加拿大
• 亚太地区
• 中国
• 日本
• 印度
• 韩国
• 澳大利亚
• 印度尼西亚
• 其他
• 欧洲
• 德国
• 法国
• 英国
• 意大利
• 西班牙
• 俄罗斯
• 其他
• 拉丁美洲
• 巴西
• 墨西哥
• 其他
• 中东和非洲

本报告中回答的关键问题

• 1.2022年全球干细胞製造市场规模有多大？
• 2.2023-2028年全球干细胞製造市场的预期增长率是多少？
• 3. 推动全球干细胞製造市场的关键因素是什么？
• 4.COVID-19 对全球干细胞製造市场有何影响？
• 5. 按产品划分的全球干细胞製造市场是怎样的？
• 6. 按应用细分的干细胞製造全球市场是怎样的？
• 7. 全球干细胞製造市场的最终用户细分情况如何？
• 8. 全球干细胞製造市场的主要区域有哪些？
• 9.9. 全球干细胞製造市场的主要参与者/公司有哪些？

内容

第一章前言

第 2 章研究方法和范围

• 调查的目的
• 利益相关者
• 数据源
  • 主要信息
  • 次要信息
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第 3 章执行摘要

第四章介绍

• 概览
• 主要行业趋势

第 5 章全球干细胞製造市场

• 市场概览
• 市场结果
• COVID-19 的影响
• 市场预测

第 6 章按产品划分的市场细分

• 消耗品
  • 市场趋势
  • 主要细分市场
    • 培养基
    • 其他
  • 市场预测
• 仪器
  • 市场趋势
  • 主要细分市场
    • 生物反应器和培养箱
    • 细胞分选员
    • 其他
  • 市场预测
• 干细胞系
  • 市场趋势
  • 主要细分市场
    • 造血干细胞 (HSC)
    • 间充质干细胞 (MSC)
    • 诱导多能干细胞 (iPSC)
    • 胚胎干细胞 (ESC)
    • 神经干细胞 (NSC)
    • 多能成体祖细胞
  • 市场预测

第 7 章应用市场细分

• 调查的申请
  • 市场趋势
  • 主要细分市场
    • 生命科学研究
    • 药物发现和药物开发
  • 市场预测
• 临床应用
  • 市场趋势
  • 主要细分市场
    • 同种异体干细胞疗法
    • 自体干细胞疗法
  • 市场预测
• 细胞和组织库应用
  • 市场趋势
  • 市场预测

第 8 章最终用户市场细分

• 製药和生物技术公司
  • 市场趋势
  • 市场预测
• 学术机构、研究机构、合同研究机构
  • 市场趋势
  • 市场预测
• 医院、手术中心
  • 市场趋势
  • 市场预测
• 细胞/组织库
  • 市场趋势
  • 市场预测
• 其他
  • 市场趋势
  • 市场预测

第 9 章按区域划分的市场细分

• 北美
  • 美国
    • 市场趋势
    • 市场预测
  • 加拿大
    • 市场趋势
    • 市场展望
• 亚太地区
  • 中国
    • 市场趋势
    • 市场展望
  • 日本
    • 市场趋势
    • 市场预测
  • 印度
    • 市场趋势
    • 市场展望
  • 韩国市场
    • 市场趋势
    • 市场展望
  • 澳大利亚
    • 市场趋势
    • 市场展望
  • 印度尼西亚
    • 市场趋势
    • 市场展望
  • 其他
    • 市场趋势
    • 市场预测
• 欧洲
  • 德国
    • 市场趋势
    • 市场展望
  • 法国
    • 市场趋势
    • 市场预测
  • 英国
    • 市场趋势
    • 市场预测
  • 意大利
    • 市场趋势
    • 市场展望
  • 西班牙
    • 市场趋势
    • 市场展望
  • 俄罗斯
    • 市场趋势
    • 市场展望
  • 其他
    • 市场趋势
    • 市场预测
• 拉丁美洲
  • 巴西
    • 市场趋势
    • 市场展望
  • 墨西哥
    • 市场趋势
    • 市场展望
  • 其他
    • 市场趋势
    • 市场预测
• 中东和非洲
  • 市场趋势
  • 按国家/地区划分的市场细分
  • 市场展望

第 10 章 SWOT 分析

• 概览
• 强度
• 弱点
• 机会
• 威胁

第11章价值链分析

第12章搬运工五力分析

• 概览
• 买家的议价能力
• 供应商的议价能力
• 竞争程度
• 新进入者的威胁
• 替代品的威胁

第 13 章：价格分析

第14章竞争格局

• 市场结构
• 主要公司
• 主要公司简介
  • Anterogen Co. Ltd.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • Corning Incorporated
  • FUJIFILM Holdings Corporation
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

The global stem cell manufacturing market size reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Stem cells are undifferentiated or partially differentiated cells that make up the tissues and organs of animals and plants. They are commonly sourced from blood, bone marrow, umbilical cord, embryo, and placenta. Under the right body and laboratory conditions, stem cells can divide to form more cells, such as red blood cells (RBCs), platelets, and white blood cells, which generate specialized functions. They are widely used for human disease modeling, drug discovery, development of cell therapies for untreatable diseases, gene therapy, and tissue engineering. Stem cells are cryopreserved to maintain their viability and minimize genetic change and are consequently used later to replace damaged organs and tissues and treat various diseases.

Stem Cell Manufacturing Market Trends:

• The global market is primarily driven by the increasing venture capital (VC) investments in stem cell research due to the rising awareness about the therapeutic potency of stem cells. Apart from this, the widespread product utilization in effective disease management, personalized medicine, and genome testing applications are favoring the market growth. Additionally, the incorporation of three-dimensional (3D) printing and microfluidic technologies to reduce production time and lower cost by integrating multiple production steps into one device is providing an impetus to the market growth. Furthermore, the increasing product utilization in the pharmaceutical industry for manufacturing hematopoietic stem cells (HSC)- and mesenchymal stem cells (MSC)-based drugs for treating tumors, leukemia, and lymphoma is acting as another growth-inducing factor. Moreover, the increasing product application in research applications to produce new drugs that assist in improving functions and altering the progress of diseases is providing a considerable boost to the market. Other factors, including the increasing usage of the technique in tissue and organ replacement therapies, significant improvements in medical infrastructure, and the implementation of various government initiatives promoting public health, are anticipated to drive the market.

Key Market Segmentation:

• IMARC Group provides an analysis of the key trends in each sub-segment of the global stem cell manufacturing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

• Consumables
• Culture Media
• Others
• Instruments
• Bioreactors and Incubators
• Cell Sorters
• Others
• Stem Cell Lines
• Hematopoietic Stem Cells (HSC)
• Mesenchymal Stem Cells (MSC)
• Induced Pluripotent Stem Cells (iPSC)
• Embryonic Stem Cells (ESC)
• Neural Stem Cells (NSC)
• Multipotent Adult Progenitor Stem Cells

Breakup by Application:

• Research Applications
• Life Science Research
• Drug Discovery and Development
• Clinical Application
• Allogenic Stem Cell Therapy
• Autologous Stem Cell Therapy
• Cell and Tissue Banking Applications

Breakup by End User:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes, Research Laboratories and Contract Research Organizations
• Hospitals and Surgical Centers
• Cell and Tissue banks
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

• The competitive landscape of the industry has also been examined along with the profiles of the key players being Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

• 1. What was the size of the global stem cell manufacturing market in 2022?
• 2. What is the expected growth rate of the global stem cell manufacturing market during 2023-2028?
• 3. What are the key factors driving the global stem cell manufacturing market?
• 4. What has been the impact of COVID-19 on the global stem cell manufacturing market?
• 5. What is the breakup of the global stem cell manufacturing market based on product?
• 6. What is the breakup of the global stem cell manufacturing market based on the application?
• 7. What is the breakup of the global stem cell manufacturing market based on the end user?
• 8. What are the key regions in the global stem cell manufacturing market?
• 9. Who are the key players/companies in the global stem cell manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Culture Media
    • 6.1.2.2 Others
  • 6.1.3 Market Forecast
• 6.2 Instruments
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Bioreactors and Incubators
    • 6.2.2.2 Cell Sorters
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast
• 6.3 Stem Cell Lines
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Hematopoietic Stem Cells (HSC)
    • 6.3.2.2 Mesenchymal Stem Cells (MSC)
    • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
    • 6.3.2.4 Embryonic Stem Cells (ESC)
    • 6.3.2.5 Neural Stem Cells (NSC)
    • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
  • 6.3.3 Market Forecast

7 Market Breakup by Application

• 7.1 Research Applications
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Life Science Research
    • 7.1.2.2 Drug Discovery and Development
  • 7.1.3 Market Forecast
• 7.2 Clinical Application
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Allogenic Stem Cell Therapy
    • 7.2.2.2 Autologous Stem Cell Therapy
  • 7.2.3 Market Forecast
• 7.3 Cell and Tissue Banking Applications
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Pharmaceutical & Biotechnology Companies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hospitals and Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Cell and Tissue banks
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Anterogen Co. Ltd.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Bio-Rad Laboratories Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Bio-Techne Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 Corning Incorporated
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 FUJIFILM Holdings Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Lonza Group AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Merck KGaA
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Sartorius AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Takara Bio Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
  • 14.3.11 Thermo Fisher Scientific Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis

List of Figures

• Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
• Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion US$), 2017-2022
• Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
• Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2022
• Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2022
• Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2022
• Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2022
• Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
• Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2022
• Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
• Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
• Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2022 and 2028
• Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million US$), 2023-2028
• Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
• Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million US$), 2023-2028
• Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
• Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
• Table 7: Global: Stem Cell Manufacturing Market: Key Players